Efficacy of booster doses in augmenting waning immune responses to COVID-19 vaccine in patients with cancer.
Cancer Cell
; 40(1): 3-5, 2022 01 10.
Article
in English
| MEDLINE | ID: covidwho-1517077
ABSTRACT
Anti-COVID-19 immunity dynamics were assessed in patients with cancer in a prospective clinical trial. Waning of immunity was detected 4-6 months post-vaccination with significant increases in anti-spike IgG titers after booster dosing, and 56% of seronegative patients seroconverted post-booster vaccination. Prior anti-CD20/BTK inhibitor therapy was associated with reduced vaccine efficacy.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Immunoglobulin G
/
Immunization, Secondary
/
COVID-19 Vaccines
/
SARS-CoV-2
/
COVID-19
/
Antibodies, Viral
/
Neoplasms
Type of study:
Cohort study
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Topics:
Long Covid
/
Vaccines
Limits:
Humans
Language:
English
Journal:
Cancer Cell
Journal subject:
Neoplasms
Year:
2022
Document Type:
Article
Affiliation country:
J.ccell.2021.11.006
Similar
MEDLINE
...
LILACS
LIS